News Conference News ACC 2026 SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients Michael O'Riordan March 30, 2026
News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV Michael O'Riordan March 29, 2026
News Conference News ACC 2026 Barbershop Effort Falls Short for Hypertension Prevention in Black Men Todd Neale March 29, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE Yael L. Maxwell March 28, 2026
News Conference News ACC 2026 KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension Caitlin E. Cox March 28, 2026
News Conference News ACC 2026 CHAMPION-AF: A Win for Watchman FLX, but With Caveats Todd Neale March 28, 2026
News Daily News Genomics, Lipids, Inflammation at Midlife Predict Future CAD Caitlin E. Cox March 25, 2026
News Daily News Several Factors Linked to Subsequent Events After TIA, Minor Stroke Todd Neale March 23, 2026
News Daily News Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race L.A. McKeown March 23, 2026
News Daily News Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1 Caitlin E. Cox March 19, 2026
News Daily News Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk Yael L. Maxwell March 19, 2026
News Conference News Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF Caitlin E. Cox March 18, 2026
News Daily News No Major Progress on Making CV Care More Affordable: JACC Stats Todd Neale March 18, 2026
News Daily News Ultraprocessed Food Again Linked to Higher CVD Risk: MESA Michael O'Riordan March 17, 2026
News Daily News Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA Yael L. Maxwell March 16, 2026
News Daily News Stress May Augment Impact of Adverse Pregnancy Outcomes on CV Health Caitlin E. Cox March 16, 2026
News Daily News Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines Michael O'Riordan March 13, 2026
News Conference News CRT 2026 DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients L.A. McKeown March 09, 2026